论文部分内容阅读
目的观察适形放疗同步化疗治疗食管癌的近期疗效。方法选取2013年12月至2016年12月期间在我院治疗的40例食管癌患者。将所有患者简单随机分为实验组和对照组,每组患者为20例。对照组食管癌患者仅使用适形放疗治疗,实验组患者采用适形放疗同步化疗治疗,对比2组食管癌患者的近期治疗效果和毒副反应。结果治疗完成后,实验组总有效率为90.00%,显著较对照组高,P<0.05;两组毒副反应比较无显著差异,P>0.05。结论适形放疗同步化疗用于治疗食管癌患者的近期疗效较好,毒副反应可耐受,值得推广。
Objective To observe the short-term curative effect of conformal radiotherapy and concurrent chemotherapy for esophageal cancer. Methods Forty esophageal cancer patients treated in our hospital from December 2013 to December 2016 were selected. All patients were randomly divided into experimental group and control group, with 20 cases in each group. The control group of esophageal cancer patients treated with conformal radiotherapy only, the experimental group of patients treated with conformal radiotherapy and concurrent chemotherapy, compared with two groups of esophageal cancer patients with short-term treatment effect and side effects. Results After the treatment, the total effective rate in the experimental group was 90.00%, significantly higher than that in the control group (P <0.05). There was no significant difference in the side effects between the two groups (P> 0.05). Conclusion Concurrent radiotherapy combined with chemotherapy for the treatment of patients with esophageal cancer better efficacy, toxicity can be tolerated, it is worth promoting.